Search Results - "dos Santos, Laise Aline Martins"
-
1
LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Published in PloS one (14-04-2015)“…Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that extends from simple steatosis to non-alcoholic steatohepatitis…”
Get full text
Journal Article -
2
Intraurethral injection with LPS: an effective experimental model of prostatic inflammation
Published in Inflammation research (2018)“…Objective Chronic inflammation has been recognized as having a prominent role pathogenesis of benign prostatic hyperplasia (BPH) and cancer. It is believed…”
Get full text
Journal Article -
3
Characterization and evaluation of nanoencapsulated diethylcarbamazine in model of acute hepatic inflammation
Published in International immunopharmacology (01-09-2017)“…Previous studies from our laboratory have demonstrated that Diethylcarbamazine (DEC) is a potent anti-inflammatory drug. The aim of the present study was to…”
Get full text
Journal Article -
4
Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice
Published in Clinical and experimental pharmacology & physiology (01-04-2015)“…Summary Alcoholic liver disease is a major cause of chronic liver disease worldwide. Diethylcarbamazine (DEC) is a drug that has anti‐inflammatory properties…”
Get full text
Journal Article -
5
New thiazolidinedione LPSF/GQ-2 inhibits NFκB and MAPK activation in LPS-induced acute lung inflammation
Published in International immunopharmacology (01-04-2018)“…Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are responsible for high mortality rates in critical patients. Despite >50 years of…”
Get full text
Journal Article -
6
A new diethylcarbamazine formulation (NANO-DEC) as a therapeutic tool for hepatic fibrosis
Published in International immunopharmacology (01-11-2018)“…The aim of the present study was to assess if the uninterrupted and prolonged administration of nanoparticles containing diethylcarbamazine (NANO-DEC) would…”
Get full text
Journal Article -
7
New thiazolidinedione LPSF/GQ-2 inhibits NF?B and MAPK activation in LPS-induced acute lung inflammation
Published in International immunopharmacology (01-04-2018)“…Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are responsible for high mortality rates in critical patients. Despite >50 years of…”
Get full text
Journal Article -
8
Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57 BL /6 mice
Published in Clinical and experimental pharmacology & physiology (01-04-2015)“…Summary Alcoholic liver disease is a major cause of chronic liver disease worldwide. Diethylcarbamazine ( DEC ) is a drug that has anti‐inflammatory properties…”
Get full text
Journal Article